← Leaderboards
Mingxia Gu
Cincinnati Childrens Hosp Med Ctr
$2,390,591
Attributed
$2,390,591
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $660.4K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,390,591 · 3
By mechanism
R01$1,307,495 · 1
R00$747,000 · 1
K99$336,096 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Tanya Kalin$7,313,192
- James M Wells$16,596,466
- Aaron M Zorn$31,248,424
- Talia S Nasr$172,827
- Joshua Waxman$11,647,448
Others in their field
Other Emerging Leaders on “Endothelial Cells”
- Zhen Zhao · University Of Southern California$7,697,905
- Roham Zamanian · Stanford University$6,654,663
- Jesse M Engreitz · Stanford University$6,568,785
- Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru$5,924,974
- Anthony J St Leger · University Of Pittsburgh At Pittsburgh$5,478,137
- Zhiyu Dai · University Of Arizona$5,148,681
Research focus
Endothelial CellsGene ExpressionTranscriptomicsSignal TransductionMolecularGenesLeadInduced Pluripotent Stem CellMutationSignal PathwayPreventPathway InteractionsLungBlood VesselsCellsEndotheliumCollaborationsCrispr/Cas TechnologyBirc3 GeneBiological SciencesAdhesionsDiagnosisCell PhysiologyCell Survival
Grant awards (7)
Elucidating the FOXF1 gene regulatory network in human alveologenesis$647,144
R01 · FY2024 · HL · contact PI
Elucidating the FOXF1 gene regulatory network in human alveologenesis$660,351
R01 · FY2023 · HL · contact PI
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension$249,000
R00 · FY2022 · HL · contact PI
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension$249,000
R00 · FY2021 · HL · contact PI
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension$249,000
R00 · FY2020 · HL · contact PI
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension$168,048
K99 · FY2018 · HL · contact PI
Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension$168,048
K99 · FY2017 · HL · contact PI